PreetChaudharyMDPhD
Oncology • Los Angeles, CAHematologic Oncology
Professor and Chief, Nohl Division of Hematology, USC School of Medicine Director, Blood and Marrow Transplant Program, USC Bloom Family Chair in Lymphoma Research
Dr. Chaudhary is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1441 Eastlake Ave
Nor8302e
Los Angeles, CA 90089Phone+1 323-865-3105Fax+1 323-865-0061
Summary
- Dr. Preet Chaudhary is an oncologist in Los Angeles, CA and is affiliated with multiple hospitals in the area, including Keck Hospital of USC, LAC+USC Medical Center, and USC Norris Comprehensive Cancer Center. He received his medical degree from Maulana Azad Medical College and has been in practice 29 years. He specializes in hematologic oncology and is experienced in hematologic malignancies, bone marrow transplant and CAR-T therapies.
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 1994 - 1997
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1992 - 1994
University of Illinois at ChicagoPhD, Genetics, 1988 - 1992
Maulana Azad Medical CollegeClass of 1988
Certifications & Licensure
PA State Medical License 2004 - 2026
TX State Medical License 1999 - 2026
CA State Medical License 2010 - 2025
WA State Medical License 1994 - 2005
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2004
Publications & Presentations
PubMed
- Philadelphia-like B-cell acute lymphoblastic leukaemia: Disease features and outcomes in the era of immunotherapy.Karam Ashouri, Brian Hom, Anush A Ginosyan, Yekta Rahimi, Karen Resnick
British Journal of Haematology. 2024-12-01 - Combination Therapy With Asciminib and Ponatinib as a Bridge to Brexucabtagene Autoleucel and Maintenance in a Patient With Relapsed Refractory Philadelphia Positive B...Alina Amin Muhammad, Erum Mir Ghazi, Amir Ali, Eric Tam, Karrune Woan
Journal of Medical Cases. 2024-10-01 - Graft Versus Host Disease Prophylaxis in Matched Donor Stem Cell Transplantation: Post-transplantation Cyclophosphamide Combinations Versus Methotrexate/Tacrolimus.Karam Ashouri, Eduardo Fernandez, Anush Ginosyan, Carissa M Feliciano, Brian Hom
Transplantation Proceedings. 2024-09-01
Authored Content
- Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs.April 1993
- ). Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes.December 1992
- Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cellsJuly 1991
Press Mentions
The California Institute for Regenerative Medicine (CIRM) Awards $5.8 Million for Prostate Cancer Research to USCMay 25th, 2022- USC Blood and Marrow Transplant Program Is Top in Nation for Adult Allogeneic TransplantsMarch 4th, 2021
- USC Alumna Rekha Prakash Brings Biotech Background to Roosevelt High SchoolFebruary 9th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
